Decoding PFIC: Clinical Red Flags & New Treatment Paradigms

What if a rare liver condition in children was being misdiagnosed until it was almost too late? In this episode, we dive into the clinical spectrum of Progressive Familial Intrahepatic Cholestasis (PFIC) with Emily Ventura, RN, BSN, CCRN. Discover the early warning signs, ground-breaking IBAT inhibitor treatments, and what every healthcare provider and caregiver needs to know to improve patient outcomes. About This Video Progressive familial intrahepatic cholestasis (PFIC) is a rare, complex group of genetic liver disorders characterized by severe cholestatic pruritus, impaired bile acid transport, and rapid progression to liver failure if unrecognized. In this interview, Emily Ventura breaks down the vital role of early genetic subtyping, clinical red flags in pediatric and adult populations, the debilitating impact of cholestatic pruritus, and how new targeted therapies are changing the treatment landscape. Key Takeaways & Topics Covered Understanding the Spectrum: Why precise genetic subtyping is critical to inform prognosis and personalized care. Early Diagnostic Red Flags: Identifying subtle cues like maternal cholestasis of pregnancy, early infant jaundice, and persistent symptoms post-cholecystectomy. Diagnostic Workup: The role of monitoring serum bile acids, serial liver panels, and fat-soluble vitamin levels. Treatment Advances: How IBAT inhibitors are helping patients delay or avoid liver transplants, plus a look at emerging gene-targeted therapies. The Reality of Cholestatic Pruritus: Managing intractable itching, sleep disruption, and the profound psychosocial toll on patients and families. About the Speaker Emily Ventura, RN, BSN, CCRN is the Executive Director and Co-Founder of the ‪@pficnetwork5830‬ Network. Drawing from her professional background as a critical care nurse and her personal experience as the parent of a teenager living with PFIC type 2 (BSEP deficiency), Emily is dedicated to empowering families, connecting patient communities with essential resources, and advancing clinical research in rare pediatric liver disease. #PFIC #RareDisease #PediatricHepatology #Genetics #LiverDisease #Cholestasis #IBATInhibitors #PatientAdvocacy #Nursing #MedicalEducation